What is ImaginAb's official website?

ImaginAb's official website is http://www.imaginab.com.

Who is the founder of ImaginAb?

ImaginAb was founded by Anna M. Wu, Christian Behrenbruch, Robert E. Reiter.

Where is ImaginAb's headquarters?

ImaginAb is located in United States, California.

ImaginAb, Inc.:Company Profile & Technical Research,Competitor Monitor,Market Trends - Discovery

Q: What is ImaginAb's industry?

ImaginAbis in the industry of: Pharmaceutical and Medicine Manufacturing

Request Demo

http://www.imaginab.com

ImaginAb is a company that provides Clinical trial, Antibody, Medicine and more. ImaginAb is headquartered in United States California. ImaginAb was founded in 2007. and was founded by Anna M. Wu, ChrMore

Basic Info

Legal Name

ImaginAb, Inc.

Founded Year

2007

Headquarter

California, United States

Core Members

Ian WilsonChief Executive Officer

Anna M. WuFounder

Robert E. ReiterFounder & Chief Medical Officer

Topics

Clinical trialAntibodyMedicineHealth careBiotechnologyMolecular imagingBiomedicineMedical imagingKineticsNew classAutoimmune diseaseBiochemistryCompanion diagnosticExosomePatient recruitmentHolographic imagingTeleradiologyImmunohistochemistryImmunotherapyBiobank

Data Snapshot

Funding Round

Total Funding Rounds

$ 59.64 M

Total Amount

News

114

Total News

Research Funding

Total Research Funding

$ 5.18 M

Total Value

Grant

Total Projects

$ 4.98 M

Total Amount

ImaginAb Frequently Asked Questions

What is ImaginAb's industry?

ImaginAb is in the industry of: Pharmaceutical and Medicine Manufacturing

What technical fields has ImaginAb researched?

ImaginAb has researched the technical fields related to Clinical trialAntibodyMedicineHealth careBiotechnologyMolecular imagingBiomedicineMedical imagingKineticsNew classAutoimmune diseaseBiochemistryCompanion diagnosticExosomePatient recruitmentHolographic imagingTeleradiologyImmunohistochemistryImmunotherapyBiobank

What kind of company is ImaginAb?

ImaginAb is a biotechnology company focused on developing a new class of highly targeted diagnostic imaging agents based on engineered antibody fragments....